COM:SPRINGWORKSTX
SpringWorks Therapeutics
- Stock
Last Close
36.30
22/11 21:00
Market Cap
2.93B
Beta: -
Volume Today
1.41M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 1.55M - | |||||||
average payables | 528.50K - | 1.71M 224.31% | 2.00M 16.80% | 2.39M 19.36% | 5.72M 139.36% | 7.70M 34.68% | ||
average receivables | 2.96M - | |||||||
book value per share | -0.87 - | 24.26 2,880.26% | 12.87 46.97% | 8.71 32.30% | -10.69 222.79% | 0.01 100.09% | ||
capex per share | -0.01 - | -0.05 282.34% | -0.01 70.62% | -0.04 180.36% | -0.19 360.27% | -0.00 99.94% | ||
capex to depreciation | -17.24 - | -3.49 79.75% | -1.84 47.28% | -4.11 123.66% | -13.33 223.95% | -4.43 66.76% | ||
capex to operating cash flow | 0.02 - | 0.01 29.12% | 0.02 41.22% | 0.02 20.95% | 0.06 300.30% | 0.03 47.48% | ||
capex to revenue | -0.02 - | -1.66 - | -1.36 18.26% | |||||
cash per share | 2.06 - | 24.68 1,100.14% | 11.74 52.42% | 7.70 34.42% | 11.11 44.30% | 0.01 99.93% | ||
days of inventory on hand | 2.68K - | |||||||
days payables outstanding | 6.40K - | |||||||
days sales outstanding | 397.37 - | |||||||
debt to assets | 0.00 - | 0.00 39.87% | 0.01 192.03% | 0.01 16.70% | ||||
debt to equity | 0.00 - | 0.00 37.73% | -0.01 401.45% | 0.01 222.31% | ||||
dividend yield | ||||||||
earnings yield | -0.04 - | -0.11 202.20% | -0.01 86.85% | -0.06 308.97% | -0.20 243.25% | -0.00 99.93% | ||
enterprise value | -10.27M - | 456.64M 4,545.92% | 183.30M 59.86% | 3.00B 1,534.38% | 2.90B 3.09% | 1.32B 54.40% | 2.30T 173,927.18% | |
enterprise value over ebitda | -24.72 - | -3.10 87.44% | -65.16 1,999.08% | -16.78 74.24% | -4.72 71.90% | -6.72K 142,299.57% | ||
ev to operating cash flow | -31.05 - | -3.86 87.56% | -93.06 2,308.80% | -22.70 75.60% | -8.19 63.91% | -10.34K 126,098.31% | ||
ev to sales | 85.59 - | 215.36 - | 422.96K 196,291.60% | |||||
free cash flow per share | -0.68 - | -3.62 436.35% | -0.76 79.08% | -2.68 253.22% | -3.22 20.34% | -0.00 99.89% | ||
free cash flow yield | -0.03 - | -0.09 215.34% | -0.01 88.90% | -0.04 313.28% | -0.12 186.76% | -0.00 99.92% | ||
graham net net | -1.00 - | 23.72 2,481.19% | 11.30 52.36% | 7.08 37.35% | 9.76 37.85% | 0.01 99.94% | ||
graham number | 3.97 - | 47.45 1,095.42% | 17.20 63.76% | 26.46 53.83% | 35.18 33.00% | 0.03 99.90% | ||
income quality | 0.83 - | 0.81 1.44% | 0.71 13.19% | 0.74 4.10% | 0.58 20.80% | 0.69 17.67% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 366.89 - | |||||||
interest debt per share | 0.06 - | 0.03 57.84% | 0.08 216.23% | 0.00 99.87% | ||||
inventory turnover | 0.14 - | |||||||
invested capital | 0.00 - | 0.00 37.73% | -0.01 401.45% | 0.01 222.31% | ||||
market cap | 502.29M - | 510.95M 1.72% | 3.14B 514.57% | 3.01B 4.27% | 1.39B 53.89% | 2.30T 166,125.08% | ||
net current asset value | -2.67M - | -20.73M 677.53% | 318.60M 1,636.99% | 494.26M 55.14% | 352.81M 28.62% | 527.71M 49.57% | 401.34M 23.95% | |
net debt to ebitda | 2.47 - | 5.55 124.57% | 3.14 43.42% | 0.59 81.10% | 0.22 62.64% | 0.49 122.18% | ||
net income per share | -0.80 - | -4.13 413.99% | -1.02 75.23% | -3.57 249.53% | -5.14 44.04% | -0.01 99.90% | ||
operating cash flow per share | -0.66 - | -3.57 439.42% | -0.74 79.20% | -2.64 254.67% | -3.03 14.98% | -0.00 99.88% | ||
payables turnover | 0.06 - | |||||||
receivables turnover | 0.92 - | |||||||
research and ddevelopement to revenue | 1.48 - | 23.77 - | 27.63 16.22% | |||||
return on tangible assets | -0.37 - | -0.16 55.57% | -0.08 53.05% | -0.38 398.51% | -0.44 13.64% | -0.45 2.97% | ||
revenue per share | 0.81 - | 0.12 - | 0.00 99.93% | |||||
roe | 0.92 - | -0.17 118.49% | -0.08 53.29% | -0.41 416.30% | 0.48 217.31% | -0.52 207.92% | ||
roic | 0.99 - | -0.17 117.43% | -0.08 53.72% | -0.41 408.52% | 0.50 221.96% | -0.54 208.04% | ||
sales general and administrative to revenue | 0.84 - | 21.89 - | ||||||
shareholders equity per share | -0.87 - | 24.26 2,880.26% | 12.87 46.97% | 8.71 32.30% | -10.69 222.79% | 0.01 100.09% | ||
stock based compensation to revenue | 0.29 - | 11.87 - | 17.36 46.21% | |||||
tangible asset value | -2.63M - | -19.37M 637.87% | 322.07M 1,762.82% | 557.06M 72.96% | 422.40M 24.17% | 558.19M 32.15% | 626.22M 12.19% | |
tangible book value per share | -0.87 - | 24.26 2,880.26% | 12.87 46.97% | 8.71 32.30% | 10.47 20.26% | 0.01 99.91% | ||
working capital | 9.89M - | 43.35M 338.44% | 319.39M 636.72% | 495.79M 55.23% | 352.94M 28.81% | 548.71M 55.47% | 422.74M 22.96% |
All numbers in USD (except ratios and percentages)